Interfering with inflammation: heterogeneous effects of interferons in graft-versus-host disease of the gastrointestinal tract and inflammatory bowel disease
Abstract: The intestine can be the target of several immunologically mediated diseases, including graft-versus-host disease (GVHD) and inflammatory bowel disease (IBD). GVHD is a life-threatening complication that occurs after allogeneic hematopoietic stem cell transplantation. Involvement of the gastrointestinal tract is associated with a particularly high mortality. GVHD development starts with the recognition of allo-antigens in the recipient by the donor immune system, which elicits immune-mediated damage of otherwise healthy tissues. IBD describes a group of immunologically mediated chronic inflammatory diseases of the intestine. Several aspects, including genetic predisposition and immune dysregulation, are responsible for the development of IBD, with Crohn’s disease and ulcerative colitis being the two most common variants. GVHD and IBD share multiple key features of their onset and development, including intestinal tissue damage and loss of intestinal barrier function. A further common feature in the pathophysiology of both diseases is the involvement of cytokines such as type I and II interferons (IFNs), amongst others. IFNs are a family of protein mediators produced as a part of the inflammatory response, typically to pathogens or malignant cells. Diverse, and partially paradoxical, effects have been described for IFNs in GVHD and IBD. This review summarizes current knowledge on the role of type I, II and III IFNs, including basic concepts and controversies about their functions in the context of GVHD and IBD. In addition, therapeutic options, research developments and remaining open questions are addressed
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Frontiers in immunology. - 12 (2021) , 705342, ISSN: 1664-3224
- Event
-
Veröffentlichung
- (where)
-
Freiburg
- (who)
-
Universität
- (when)
-
2021
- Creator
- DOI
-
10.3389/fimmu.2021.705342
- URN
-
urn:nbn:de:bsz:25-freidok-2196233
- Rights
-
Kein Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Haring, Eileen
- Zeiser, Robert
- Apostolova, Petya
- Universität
Time of origin
- 2021
Other Objects (12)
Advances in understanding the pathogenesis of graft‐versus‐host disease
Immunomodulatory therapies for the treatment of graft-versus-host disease
Kinase inhibition as treatment for acute and chronic graft-versus-host disease
The role of purine metabolites as DAMPs in acute graft-versus-host disease
The role of MicroRNAs in myeloid cells during graft-versus-host disease
Acute graft-versus-host disease, infections, vascular events and drug toxicities affecting the central nervous system
Deciphering the role of the major histocompatibility complex, the intestinal microbiome and metabolites in the pathogenesis of acute graft-versus-host disease
Extracorporeal photopheresis in acute and chronic steroid‑refractory graft-versus-host disease: an evolving treatment landscape
Modulation of gastrointestinal graft-versus-host disease via the Enteroenedocrine glucagon-like peptide 2 (GLP-2)
Die Rolle von extrazellulärem ATP bei der Entstehung der akuten Graft-©versus-©Host Erkrankung
Editorial on translational research in graft-versus-host disease (GVHD) and graft-versus-tumor (GVT) effect after allogeneic hematopoietic cell transplantation
Editorial: Non-coding RNAs and graft versus host disease
Advances in understanding the pathogenesis of graft‐versus‐host disease
Immunomodulatory therapies for the treatment of graft-versus-host disease
Kinase inhibition as treatment for acute and chronic graft-versus-host disease
The role of purine metabolites as DAMPs in acute graft-versus-host disease
The role of MicroRNAs in myeloid cells during graft-versus-host disease
Acute graft-versus-host disease, infections, vascular events and drug toxicities affecting the central nervous system
Deciphering the role of the major histocompatibility complex, the intestinal microbiome and metabolites in the pathogenesis of acute graft-versus-host disease
Extracorporeal photopheresis in acute and chronic steroid‑refractory graft-versus-host disease: an evolving treatment landscape
Modulation of gastrointestinal graft-versus-host disease via the Enteroenedocrine glucagon-like peptide 2 (GLP-2)
Die Rolle von extrazellulärem ATP bei der Entstehung der akuten Graft-©versus-©Host Erkrankung
Editorial on translational research in graft-versus-host disease (GVHD) and graft-versus-tumor (GVT) effect after allogeneic hematopoietic cell transplantation
Editorial: Non-coding RNAs and graft versus host disease
Advances in understanding the pathogenesis of graft‐versus‐host disease
Immunomodulatory therapies for the treatment of graft-versus-host disease
Kinase inhibition as treatment for acute and chronic graft-versus-host disease
The role of purine metabolites as DAMPs in acute graft-versus-host disease
The role of MicroRNAs in myeloid cells during graft-versus-host disease
Acute graft-versus-host disease, infections, vascular events and drug toxicities affecting the central nervous system
Deciphering the role of the major histocompatibility complex, the intestinal microbiome and metabolites in the pathogenesis of acute graft-versus-host disease
Extracorporeal photopheresis in acute and chronic steroid‑refractory graft-versus-host disease: an evolving treatment landscape
Modulation of gastrointestinal graft-versus-host disease via the Enteroenedocrine glucagon-like peptide 2 (GLP-2)
Die Rolle von extrazellulärem ATP bei der Entstehung der akuten Graft-©versus-©Host Erkrankung
Editorial on translational research in graft-versus-host disease (GVHD) and graft-versus-tumor (GVT) effect after allogeneic hematopoietic cell transplantation